Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-027209
Filing Date
2018-05-10
Accepted
2018-05-10 17:21:56
Documents
47
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv493214_10q.htm 10-Q 272969
2 EXHIBIT 10.1 tv493214_ex10-1.htm EX-10.1 109414
3 EXHIBIT 31.1 tv493214_ex31-1.htm EX-31.1 9940
4 EXHIBIT 31.2 tv493214_ex31-2.htm EX-31.2 9364
5 EXHIBIT 32.1 tv493214_ex32-1.htm EX-32.1 4106
6 EXHIBIT 32.2 tv493214_ex32-2.htm EX-32.2 4130
  Complete submission text file 0001144204-18-027209.txt   2693753

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT abeo-20180331.xml EX-101.INS 600692
8 XBRL TAXONOMY EXTENSION SCHEMA abeo-20180331.xsd EX-101.SCH 20774
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abeo-20180331_cal.xml EX-101.CAL 25666
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abeo-20180331_def.xml EX-101.DEF 175235
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE abeo-20180331_lab.xml EX-101.LAB 178595
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abeo-20180331_pre.xml EX-101.PRE 193166
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 18824093
SIC: 2834 Pharmaceutical Preparations